Advertisement

Coccidioidomycosis - Biotech, Pharma and Life Science Channel

20:01 EDT 21st May 2013 | BioPortfolio

PubMed Articles [ 16 Associated PubMed Articles listed on BioPortfolio]

Increase in reported coccidioidomycosis - United States, 1998-2011.

Coccidioidomycosis, also known as valley fever, is an infection caused by inhalation of Coccidioides spp. spores. This soil-dwelling fungus is endemic to arid regions of Mexico, Central and South Amer...

Teaching Neuroimages: Fungus in the brain: Coccidioidomycosis meningoencephalitis.

Coccidioidal meningoencephalitis often carries a poor prognosis.(1) Brain imaging can reveal focal enhancement at the basal cisterns, infarction, and communicating hydrocephalus.(2) A 38-year-old HIV-...

Hospitalizations associated with disseminated coccidioidomycosis, Arizona and california, USA.

We analyzed hospitalization databases from Arizona and California for disseminated coccidioidomycosis-associated hospitalizations among immunocompetent persons. Racial/ethnic disease ratios were chara...

Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection.

The clinical manifestations of coccidioidomycosis vary depending upon the extent of exposure and immune status of the host. Recent studies have demonstrated an essential role for vitamin D in both inn...

Coccidioidomycosis and lung transplantation.

Coccidioidomycosis, an endemic fungal infection in the desert southwestern United States, causes substantial morbidity and mortality in immunocompromised hosts. Because lungs are the primary site of c...

Endemic systemic mycoses: coccidioidomycosis, histoplasmosis, paracoccidioidomycosis and blastomycosis.

Endemic deep or systemic mycoses are common in specific geographical areas of the world. Coccidioidomycosis is present in semi-desert areas, histoplasmosis and paracoccidioidomycosis in tropical regio...

Epidemiology of endemic systemic fungal infections in Latin America.

Although endemic mycoses are a frequent health problem in Latin American countries, clinical and epidemiological data remain scarce and fragmentary. These mycoses have a significant impact on public h...

Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007-2008.

Coccidioidomycosis is endemic to the southwestern United States; 60% of nationally reported cases occur in Arizona. Although the Council of State and Territorial Epidemiologists case definition for co...

Diagnostic contribution of the positron emission scanning with 18F-FDG for invasive fungal infections.

Abstract Background: Optimal staging and evaluation of residual lesions of invasive fungal infections (IFI) are major challenges in the immunocompromised host. Preliminary data have suggested that flu...

Disseminated primary coccidioidomycosis of the chest wall.

News Articles [ 9 Associated News Articles listed on BioPortfolio]

Valley Fever Has Increased in Several Southwestern States

Coccidioidomycosis, a fungal respiratory infection also known as Valley fever, has increased substantially in several southwestern US states since 1998.

Active Coccidioidomycosis in Solid Organ Transplant

Solid organ transplant recipients who acquire coccidioidomycosis have high rates of disseminated infection and mortality, and diagnosis of infection is challenging. Which assays, if any, are more usef...

Increase in Reported Coccidioidomycosis

Is coccidioidomycosis common? Read this new report to get the latest data on disease occurrence in the US in the last decade. Morbidity & Mortality Weekly Report

Valley Fever on rise in Southwest, CDC says

A nasty fungal infection that can spread to the lungs or brain and cause lifetime symptoms is on the rise in the Southwestern U.S., federal health officials reported on Thursday. Cases of Valley Fever...

Coccidioidomycosis Cases on the Rise in Parts of US

Symptoms of the disease, also known as "Valley Fever," can mimic Influenza. Medscape Medical News

Valley Fever Increasing in Some Southwestern States

ATLANTA, March 28, 2013 /PRNewswire-USNewswire/ -- Valley Fever, a fungal respiratory infection, dramatically increased in several southwestern states from 1998 through 2011, according to a new s...

RAPID™-PsA study showed that certolizumab pegol improved signs and symptoms of psoriatic arthritis in patients with and without prior anti-TNF exposure

ATLANTA, Nov. 14, 2012 /PRNewswire/ -- UCB announced today results from the RAPID™-PsA study at the American College of Rheumatology's (ACR) 2012 Annual Scientific Meeting in Washington, D.C., U...

Another Deadly Fungal Infection Seen in Southwest (CME/CE)

(MedPage Today) -- Although the meningitis outbreak has captured the headlines this week, another fungal infection, coccidioidomycosis, racks up an estimated 150,000 new cases in the U.S. each year, r...

Post Hoc Analysis Indicated That Timing And Magnitude Of Initial Response To Certolizumab Pegol Predicted Likelihood Of Low Disease Activity At Week 28 In Patients With Active Moderate To Severe Rheumatoid Arthritis

BERLIN and BRUSSELS, June 8, 2012 /PRNewswire/ -- UCB today announced data from a post hoc analysis of the REALISTIC (RA Evaluation in Subjects Receiving TNF Inhibitor Certolizumab Pegol) st...

Events [0 Results]

None

Companies [0 Results]

None

Clinical Trials [ 4 Associated Clinical Trials listed on BioPortfolio]

A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common

To compare the efficacy of fluconazole versus placebo in preventing the development of active coccidioidomycosis and other systemic fungal infections among HIV-infected patients with CD4 l...

Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment

The purpose of this study is to determine if nikkomycin Z is safe when administered at different dose levels for 14 days. The study will also determine blood levels and urinary excretion...

POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)

To evaluate the safety of posaconazole (POS) in the treatment of coccidioidomycosis. Period A consisted of 2 blinded arms, posaconazole and fluconazole. Recruitment was stopped, and parti...

Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis

The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.

Medical and Biotech [MESH] Definitions

Coccidioides

A mitosporic fungal genus which causes COCCIDIOIDOMYCOSIS.

Coccidioidin

A sterile solution containing the by-products of growth products of COCCIDIOIDES IMMITIS, injected intracutaneously as a test for COCCIDIOIDOMYCOSIS.

Coccidioidomycosis

Infection with a fungus of the genus COCCIDIOIDES, endemic to the SOUTHWESTERN UNITED STATES. It is sometimes called valley fever but should not be confused with RIFT VALLEY FEVER. Infection is caused by inhalation of airborne, fungal particles known as arthroconidia, a form of FUNGAL SPORES. A primary form is an acute, benign, self-limited respiratory infection. A secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. It can be detected by use of COCCIDIOIDIN.

Search BioPortfolio:
Advertisement
review and buy Coccidioidomycosis market research data and corporate reports here

Channels Quicklinks

Advertisement